320 likes | 440 Views
Functional and organic diseases of digestive tract. Etiology, pathogenesis, clinical features, diagnostics, treatment and prevention. Lecturer: Sakharova I.Ye., MD, PhD. Chronic abdominal pain. Frog position in severe crampy abdominal pain. Is it a problem? Prevalence 0.5%-19% in community
E N D
Functional and organic diseases of digestive tract. Etiology, pathogenesis, clinical features, diagnostics, treatment and prevention. Lecturer: Sakharova I.Ye., MD, PhD
Frog position in severe crampy abdominal pain
Is it a problem? • Prevalence 0.5%-19% in community • 13-17% middle/high school students weekly pain • 2-4% of paediatric office visits • Considerable morbidity, missed school days • Difficult, time-consuming and expensive to manage becauseof diagnostic uncertainty, chronicity and increasing parentalanxiety
What I’ll talk about • Definitions of functional abdominal pain • Cause of functional abdominal pain • Differentiating organic vs functional pain • Management of functional abdominal pain
Rome III criteria, 2006 • Functional dyspepsia • Irritable bowel syndrome • Functional abdominal pain • Functional abdominal pain syndrome • Abdominal migraine - No evidence of an inflammatory, anatomical, metabolic orneoplastic process - Criteria fulfilled at least once a week for at least two monthsbefore diagnosis
Functional dyspepsia • Persistent or recurrent pain or discomfort centred in theupper abdomen (above the umbilicus) • Not relieved by defecation or associated with the onset of achange in stool frequency or stool form
Recurrent abdominal pain (Apley and Naish, 1958) • Waxes and wanes • 3 episodes in 3 months • Severe enough to affect activities
Irritable bowel syndrome Abdominal discomfort (uncomfortable sensation notdescribed as pain) or pain associated with two or more of thefollowing at least 25% of the time: • Improved with defecation • Onset associated with a change in frequency of stool • Onset associated with a change in form (appearance) of stool
Functional abdominal pain • Episodic or continuous abdominal pain • Insufficient criteria for other functional gastrointestinaldisorders
Functional abdominal pain syndrome Must include functional abdominal pain at least 25% of thetime and one or more of the following: • Some loss of daily functioning • Additional somatic symptoms such as headache, limb pain, ordifficulty in sleeping
Abdominal migraine • Paroxysmal episodes of intense, acute periumbilical pain that lasts forone or more hours • Intervening periods of usual health lasting weeks to months • The pain interferes with normal activities • The pain is associated with two or more of the following: - Anorexia - Nausea - Vomiting - Headache - Photophobia - Pallor Criteria fulfilled two or more times in the preceding 12 months
What causes it? • Biopsychosocial model • Visceral sensation, disturbances in GI motility, hormonalchanges, inflammation • Psychological factors • Family dynamics • Brain-gut axis • Sexual abuse – longer duration of symptoms • Parental anxietyin first year of life associated with chronicabdo pain before age 6 • GI problems in parents
Chronic abdo pain in OPD • Organic vs functional pain • Organic pain 5% in general population, 40% in paediatricgastroenterology OPD.
Organic vs functional pain • No diagnostic tools to differentiate • Presence of alarm symptoms or signs increases theprobability of an organic disorder and justifies further tests
History and examination • Analysis of the pain • GI symptoms including bowel habit • Genitourinary symptoms • Effect on daily living • Family history – GI problems, migraine
Alarm symptoms • Involuntary weight loss • Deceleration of linear growth • Gastrointestinal blood loss • Significant vomiting • Chronic severe diarrhoea • Unexplained fever • Persistent right upper or right lower quadrant pain • Family history of inflammatory bowel disease
Organic pain - differential GI tract • Chronic constipation • Lactose intolerance • Parasite infection (Giardia) • Excess fructose/sorbitol ingestion • Crohns • Peptic ulcer • Reflux esophagitis • Meckels diverticulum • Recurrent intussusception • Hernia – internal, inguinal, abdominal wall • Chronic appendicitis
Organic pain - differential Gallbladder and pancreas • Cholelithiasis • Choledochal cyst • Recurrent pancreatitis Genitourinary tract • UTI • Hydronephrosis • Urolithiasis
Miscellaneous causes • Abdominal epilepsy • Gilberts syndrome • Familial Mediterranean fever • Sickle cell crisis • Lead poisoning • HSP • Angioneurotic edema • Acute intermittent porphyria
Diagnostic Tools • Rome III Criteria • Essential Investigations : according to symptoms e.g. - CBC - U A , Stool exam - LDG, Amylase ,lipase - Ultrasound - Barium study - Gastric emptying time test ,Intestinal transit time ,Colonic transittime test - Hydrogen breath test: lactose ,lactulose,glucose - Endoscopy - Skin Prick test - Urea Breath test
Recommendation of North American Society forPediatric Gastroenterology, Hepatology and Nutrition • Additional diagnostic evaluation is not required in childrenwithout alarm symptoms • Testing may be carried out to reassure children and theirparents
What are the predictive valuesof diagnostic tests? • There is no evidence to suggest that the use ofultrasonographic examination of the abdomenand pelvisin the absence of alarm symptoms has a significant yieldof organic disease(evidence quality C). • There is little evidence to suggest that the use ofendoscopy and biopsy in the absence of alarmsymptoms has a significant yield of organic disease (evidence quality C). • There is insufficient evidence to suggest that the use ofesophageal pH monitoring in the absence of alarmsymptoms has a significant yield of organic disease(evidence quality C).
Treatment • Deal with psychological factors • Educate the family (an important part of treatment) • Focus on return to normal functioning rather than on thecomplete disappearance of pain • Best prescribe drugs judiciously as part of amultifaceted, individualised approach, to relievesymptoms and disability
Treatment • Medicines: • Acid lowering agents • Mucoprotective drugs • Motility regulators • Laxatives • Analgesics • Probiotics • Gas adsorbants • Dietary and life style change • Psychotherapy
Pharmacologic treatmentapproach A. Antacids B. H2- receptor antagonist C. Proton pump inhibitors D. Sucralfate E. Prokinetics
Treatment of Acid-related disorders • H2-receptor Antagonists: Ranitidine (2-4 mg/kg/d up to 150 mg bid), Famotidine (1-1.2 mg/kg/d up to 20 mg bid) • PPI: Omeprazole (0.8 mg/kg/d;effective dose range of0.3-3.3 mg/kg/d), Lansoprazole (0.8 mg/kg/d) • Cytoprotective Agents: Sucralfate(40-80 mg/kg/d up to 1 g qid) Rabemipride ( 1 x 3 )
Prognosis • Majority of children mild symptoms and managed in primarycare • Studies of prognosis are mainly in referred patients • Systematic review • 29.1% of children had on-going abdo pain (follow-up ranged 1-29 yrs) • May develop irritable bowel synd as adults • Risk of later emotional symptoms and psychiatric disorders, particularly anxiety disorders
Success is not final, failure is not fatal. It is the courage to continue that counts. Winston Churchill